• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Efficacy and safety of digoxin alone and in combination with low-dose diltiazem or betaxolol to control ventricular rate in chronic atrial fibrillation.

作者信息

Koh K K, Kwon K S, Park H B, Baik S H, Park S J, Lee K H, Kim E J, Kim S H, Cho S K, Kim S S

机构信息

Department of Internal Medicine and Epidemiology, Inha University Hospital, Soojung-ku Sungnam-si, Kyunggi-do, Korea.

出版信息

Am J Cardiol. 1995 Jan 1;75(1):88-90. doi: 10.1016/s0002-9149(99)80538-4.

DOI:10.1016/s0002-9149(99)80538-4
PMID:7801876
Abstract
摘要

相似文献

1
Efficacy and safety of digoxin alone and in combination with low-dose diltiazem or betaxolol to control ventricular rate in chronic atrial fibrillation.
Am J Cardiol. 1995 Jan 1;75(1):88-90. doi: 10.1016/s0002-9149(99)80538-4.
2
Comparative study of efficacy and safety of low-dose diltiazem or betaxolol in combination with digoxin to control ventricular rate in chronic atrial fibrillation: randomized crossover study.低剂量地尔硫䓬或倍他洛尔联合地高辛控制慢性心房颤动心室率的疗效与安全性比较研究：随机交叉研究
Int J Cardiol. 1995 Nov 24;52(2):167-74. doi: 10.1016/0167-5273(95)02480-k.
3
[The use of digoxin and diltiazem in controlling ventricular rate in chronic atrial fibrillation].[地高辛与地尔硫䓬在控制慢性心房颤动心室率中的应用]
Zhonghua Xin Xue Guan Bing Za Zhi. 1990 Feb;18(1):8-10.
4
Low- and medium-dose diltiazem in chronic atrial fibrillation: comparison with digoxin and correlation with drug plasma levels.慢性心房颤动中低剂量和中剂量地尔硫䓬：与地高辛比较及与药物血浆水平的相关性
Am Heart J. 1988 Aug;116(2 Pt 1):385-92. doi: 10.1016/0002-8703(88)90610-2.
5
Acute ventricular rate control in atrial fibrillation: IV combination of diltiazem and digoxin vs. IV diltiazem alone.心房颤动的急性心室率控制：地尔硫䓬与地高辛静脉联合用药对比单独静脉使用地尔硫䓬
Chest. 2001 Feb;119(2):502-6. doi: 10.1378/chest.119.2.502.
6
Combination therapy with digoxin and diltiazem controls ventricular rate in chronic atrial fibrillation in dogs better than digoxin or diltiazem monotherapy: a randomized crossover study in 18 dogs.地高辛与地尔硫䓬联合治疗对犬慢性心房颤动心室率的控制效果优于地高辛或地尔硫䓬单一疗法：一项对18只犬的随机交叉研究。
J Vet Intern Med. 2009 May-Jun;23(3):499-508. doi: 10.1111/j.1939-1676.2009.0301.x.
7
Emergency management of atrial fibrillation and flutter: intravenous diltiazem versus intravenous digoxin.心房颤动和心房扑动的急诊处理：静脉注射地尔硫䓬与静脉注射地高辛的比较
Ann Emerg Med. 1997 Jan;29(1):135-40. doi: 10.1016/s0196-0644(97)70319-6.
8
Clinical decision analysis modeling: short-term control of ventricular response rate in atrial fibrillation or atrial flutter-digoxin versus diltiazem.临床决策分析建模：心房颤动或心房扑动时心室率的短期控制——地高辛与地尔硫䓬对比
Pharmacotherapy. 1994 Jul-Aug;14(4):446-51.
9
Efficacy and safety of medium- and high-dose diltiazem alone and in combination with digoxin for control of heart rate at rest and during exercise in patients with chronic atrial fibrillation.
Circulation. 1986 Feb;73(2):316-24. doi: 10.1161/01.cir.73.2.316.
10
Diltiazem as adjunctive oral therapy in patients with chronic atrial fibrillation.
J Assoc Physicians India. 1992 Nov;40(11):737-9.

引用本文的文献

1
Changes in local mineral homeostasis facilitate the formation of benign and malignant testicular microcalcifications.局部矿物质稳态的变化促进良性和恶性睾丸微钙化的形成。
Elife. 2025 Apr 25;13:RP95545. doi: 10.7554/eLife.95545.
2
Digoxin for atrial fibrillation and atrial flutter: A systematic review with meta-analysis and trial sequential analysis of randomised clinical trials.地高辛治疗心房颤动和心房扑动：随机临床试验的系统评价与荟萃分析和试验序贯分析。
PLoS One. 2018 Mar 8;13(3):e0193924. doi: 10.1371/journal.pone.0193924. eCollection 2018.
3
A review of rate control in atrial fibrillation, and the rationale and protocol for the RATE-AF trial.
心房颤动心率控制综述以及RATE-AF试验的基本原理和方案。
BMJ Open. 2017 Jul 20;7(7):e015099. doi: 10.1136/bmjopen-2016-015099.
4
New-onset atrial fibrillation in critically ill patients.危重症患者新发心房颤动
Can Respir J. 2015 May-Jun;22(3):179-82. doi: 10.1155/2015/394961.
5
2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines and the Heart Rhythm Society.2014年美国心脏协会/美国心脏病学会/心律学会心房颤动患者管理指南：美国心脏病学会/美国心脏协会实践指南工作组和心律学会的报告
Circulation. 2014 Dec 2;130(23):e199-267. doi: 10.1161/CIR.0000000000000041. Epub 2014 Mar 28.
6
Rate control in atrial fibrillation, insight into the RACE II study.心房颤动的心率控制：RACE II研究洞察
Neth Heart J. 2013 Apr;21(4):199-204. doi: 10.1007/s12471-013-0391-1.
7
Rate control in permanent atrial fibrillation.永久性心房颤动的心率控制
BMJ. 2007 Nov 24;335(7629):1057-8. doi: 10.1136/bmj.39365.511076.BE.
8
Digoxin and mortality in atrial fibrillation: a prospective cohort study.地高辛与心房颤动患者死亡率：一项前瞻性队列研究。
Eur J Clin Pharmacol. 2007 Oct;63(10):959-71. doi: 10.1007/s00228-007-0346-9. Epub 2007 Aug 8.
9
Rate control in atrial fibrillation: what approach is best?心房颤动的心率控制：哪种方法最佳？
Curr Cardiol Rep. 2004 Sep;6(5):351-3. doi: 10.1007/s11886-004-0037-4.
10
When, and when not, to use digoxin in the elderly.老年人何时以及何时不宜使用地高辛。
Drugs Aging. 1997 Jun;10(6):411-20. doi: 10.2165/00002512-199710060-00002.